Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Soluble ST2 serum concentration and renal function in heart failure.

Bayes-Genis A, Zamora E, de Antonio M, Galán A, Vila J, Urrutia A, Díez C, Coll R, Altimir S, Lupón J.

J Card Fail. 2013 Nov;19(11):768-75. doi: 10.1016/j.cardfail.2013.09.005.

PMID:
24263122
2.

Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency.

Kim MS, Jeong TD, Han SB, Min WK, Kim JJ.

J Korean Med Sci. 2015 May;30(5):569-75. doi: 10.3346/jkms.2015.30.5.569. Epub 2015 Apr 15.

3.

Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.

Bayes-Genis A, de Antonio M, Vila J, Peñafiel J, Galán A, Barallat J, Zamora E, Urrutia A, Lupón J.

J Am Coll Cardiol. 2014 Jan 21;63(2):158-66. doi: 10.1016/j.jacc.2013.07.087. Epub 2013 Sep 24.

4.

Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure.

Zhang R, Zhang Y, An T, Guo X, Yin S, Wang Y, Januzzi JL, Cappola TP, Zhang J.

Biomark Med. 2015;9(5):433-41. doi: 10.2217/bmm.15.12.

PMID:
25985174
5.

Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.

Lupón J, de Antonio M, Galán A, Vila J, Zamora E, Urrutia A, Bayes-Genis A.

Mayo Clin Proc. 2013 Mar;88(3):234-43. doi: 10.1016/j.mayocp.2012.09.016. Epub 2013 Feb 4. Erratum in: Mayo Clin Proc. 2013 May;88(5):532.

PMID:
23384388
6.

ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality.

Hughes MF, Appelbaum S, Havulinna AS, Jagodzinski A, Zeller T, Kee F, Blankenberg S, Salomaa V; FINRISK and BiomarCaRE investigators..

Heart. 2014 Nov;100(21):1715-21. doi: 10.1136/heartjnl-2014-305968. Epub 2014 Jul 30.

PMID:
25080471
7.

Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.

Mueller T, Leitner I, Egger M, Haltmayer M, Dieplinger B.

Clin Chim Acta. 2015 May 20;445:155-60. doi: 10.1016/j.cca.2015.03.033. Epub 2015 Apr 4.

8.

The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.

Zhang R, Zhang Y, Zhang J, An T, Huang Y, Guo X, Januzzi JL, Cappola TP, Yin S, Wang Y, Zhou Q, Zou C, Ji S, Lv R.

PLoS One. 2014 Oct 27;9(10):e110976. doi: 10.1371/journal.pone.0110976. eCollection 2014.

9.

Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea.

Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL.

Circ Heart Fail. 2009 Jul;2(4):311-9. doi: 10.1161/CIRCHEARTFAILURE.108.833707. Epub 2009 May 14.

10.

Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial.

Anand IS, Rector TS, Kuskowski M, Snider J, Cohn JN.

Circ Heart Fail. 2014 May;7(3):418-26. doi: 10.1161/CIRCHEARTFAILURE.113.001036. Epub 2014 Mar 12.

11.

Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.

Manzano-Fernández S, Mueller T, Pascual-Figal D, Truong QA, Januzzi JL.

Am J Cardiol. 2011 Jan 15;107(2):259-67. doi: 10.1016/j.amjcard.2010.09.011.

12.

Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.

Pimenta JM, Almeida R, Araújo JP, Azevedo A, Friões F, Rocha-Gonçalves F, Ferreira A, Bettencourt P.

J Card Fail. 2007 May;13(4):275-80.

PMID:
17517347
13.

Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

Pascual-Figal DA, Ordoñez-Llanos J, Tornel PL, Vázquez R, Puig T, Valdés M, Cinca J, de Luna AB, Bayes-Genis A; MUSIC Investigators..

J Am Coll Cardiol. 2009 Dec 1;54(23):2174-9. doi: 10.1016/j.jacc.2009.07.041.

14.

Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.

Felker GM, Fiuzat M, Thompson V, Shaw LK, Neely ML, Adams KF, Whellan DJ, Donahue MP, Ahmad T, Kitzman DW, Piña IL, Zannad F, Kraus WE, O'Connor CM.

Circ Heart Fail. 2013 Nov;6(6):1172-9. doi: 10.1161/CIRCHEARTFAILURE.113.000207. Epub 2013 Oct 8.

15.

Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.

Piper SE, Sherwood RA, Amin-Youssef GF, Shah AM, McDonagh TA.

Int J Cardiol. 2015 Jan 15;178:284-91. doi: 10.1016/j.ijcard.2014.11.097. Epub 2014 Nov 12.

PMID:
25465308
16.

Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.

Dieplinger B, Egger M, Haltmayer M, Kleber ME, Scharnagl H, Silbernagel G, de Boer RA, Maerz W, Mueller T.

Clin Chem. 2014 Mar;60(3):530-40. doi: 10.1373/clinchem.2013.209858. Epub 2014 Jan 8.

17.

Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure.

Bayes-Genis A, Pascual-Figal D, Januzzi JL, Maisel A, Casas T, Valdés Chávarri M, Ordóñez-Llanos J.

Rev Esp Cardiol. 2010 Oct;63(10):1171-8. English, Spanish.

18.

Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction.

Friões F, Lourenço P, Laszczynska O, Almeida PB, Guimarães JT, Januzzi JL, Azevedo A, Bettencourt P.

Clin Res Cardiol. 2015 Jun;104(6):491-9. doi: 10.1007/s00392-015-0811-x. Epub 2015 Jan 14.

PMID:
25586507
19.

Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.

Park M, Vittinghoff E, Shlipak MG, Mishra R, Whooley M, Bansal N.

Am Heart J. 2014 Dec;168(6):931-9.e2. doi: 10.1016/j.ahj.2014.09.008. Epub 2014 Oct 14.

20.

Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.

Pascual-Figal DA, Manzano-Fernández S, Boronat M, Casas T, Garrido IP, Bonaque JC, Pastor-Perez F, Valdés M, Januzzi JL.

Eur J Heart Fail. 2011 Jul;13(7):718-25. doi: 10.1093/eurjhf/hfr047. Epub 2011 May 6.

Supplemental Content

Support Center